| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.ONC.1209859 |
| P698 | PubMed publication ID | 16953230 |
| P50 | author | Daniela Gramaglia | Q63992723 |
| Andrea Rasola | Q37379515 | ||
| Paolo M. Comoglio | Q37381902 | ||
| Maria Flavia Di Renzo | Q56517324 | ||
| P2093 | author name string | D'Alessandro L | |
| De Bacco F | |||
| Fassetta M | |||
| P2860 | cites work | A large-scale RNAi screen in human cells identifies new components of the p53 pathway | Q24319883 |
| Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis | Q24556984 | ||
| The Wnt signaling pathway in development and disease | Q27861019 | ||
| Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B | Q28216726 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin | Q28512944 | ||
| Wnt signalling in stem cells and cancer | Q29547862 | ||
| Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer | Q30051055 | ||
| Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway | Q33969327 | ||
| Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency | Q73563311 | ||
| The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase | Q73816403 | ||
| Hepatocyte Growth Factor/Scatter Factor Activates the Apoptosis Signaling Pathway by Increasing Caspase-3 Activity in Sarcoma 180 Cells | Q74424409 | ||
| The Wnt signaling pathway and its role in tumor development | Q34192072 | ||
| Overexpression of components of the Frizzled-Dishevelled cascade results in apoptotic cell death, mediated by beta-catenin | Q34514475 | ||
| Molecular mechanisms of "detachment-induced apoptosis--Anoikis". | Q34629157 | ||
| Scatter-factor and semaphorin receptors: cell signalling for invasive growth | Q34632043 | ||
| Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators | Q34767825 | ||
| The ins and outs of APC and beta-catenin nuclear transport | Q34838428 | ||
| You Wnt some, you lose some: oncogenes in the Wnt signaling pathway | Q35062431 | ||
| APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits" | Q35110017 | ||
| PI3K/Akt and apoptosis: size matters | Q35603373 | ||
| Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer | Q35829554 | ||
| Signaling pathways in intestinal development and cancer | Q35912854 | ||
| Self-renewal and cancer of the gut: two sides of a coin. | Q36080124 | ||
| Wnt signaling in the intestinal epithelium: from endoderm to cancer | Q36099900 | ||
| Decisions, decisions: beta-catenin chooses between adhesion and transcription | Q36113237 | ||
| Cancer therapy: can the challenge be MET? | Q36159458 | ||
| Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection | Q38331058 | ||
| Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation | Q40408804 | ||
| Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells | Q40423758 | ||
| Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression | Q40443907 | ||
| HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion | Q40490783 | ||
| Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin | Q40583172 | ||
| Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis | Q40752904 | ||
| WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial Cells | Q41029555 | ||
| MET signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant Wnt signalling | Q42278276 | ||
| Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells | Q43746983 | ||
| A flow cytometry assay simultaneously detects independent apoptotic parameters | Q43759365 | ||
| Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin | Q44510418 | ||
| Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-X(L)- and PKB/AKT-independent fashion | Q44721176 | ||
| The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. | Q47982958 | ||
| β-Catenin activates the growth factor endothelin-1 in colon cancer cells | Q57635218 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1078-1087 | |
| P577 | publication date | 2006-09-04 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth | |
| P478 | volume | 26 |
| Q37342770 | A Distinct Slow-Cycling Cancer Stem-like Subpopulation of Pancreatic Adenocarcinoma Cells is maintained in Vivo |
| Q24644948 | A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer |
| Q37729512 | A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells |
| Q30482206 | Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. |
| Q45357168 | Berberine acts as a natural inhibitor of Wnt/β-catenin signaling--identification of more active 13-arylalkyl derivatives. |
| Q37963288 | Body plan of turtles: an anatomical, developmental and evolutionary perspective. |
| Q35591995 | Can we safely target the WNT pathway? |
| Q43805357 | Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer |
| Q26851275 | Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy |
| Q37113566 | Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination |
| Q36520856 | Cytokines, inflammation and colon cancer |
| Q34439113 | Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels |
| Q35773980 | Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. |
| Q36578803 | Decorin as a multivalent therapeutic agent against cancer. |
| Q37263981 | Decorin is a novel antagonistic ligand of the Met receptor |
| Q33903540 | Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening. |
| Q37234754 | Epimorphin deletion inhibits polyposis in theApcmin/+mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion |
| Q37826460 | Evolutionary developmental perspective for the origin of turtles: the folding theory for the shell based on the developmental nature of the carapacial ridge. |
| Q34791002 | FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis |
| Q38941681 | FOXC2 promotes colorectal cancer metastasis by directly targeting MET. |
| Q35987339 | Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion |
| Q35920503 | Fibroblasts--a key host cell type in tumor initiation, progression, and metastasis |
| Q39819780 | HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells |
| Q37213011 | Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation. |
| Q42747876 | Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies |
| Q28743270 | Hepatocyte growth factor is crucial for development of the carapace in turtles |
| Q40148697 | Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling |
| Q36597064 | Hypothermia blocks beta-catenin degradation after focal ischemia in rats |
| Q37507920 | IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer |
| Q37725907 | Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development |
| Q38922517 | Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells. |
| Q55499961 | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer. |
| Q36279559 | Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon |
| Q34662122 | MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway |
| Q30157439 | MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis |
| Q39809308 | Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. |
| Q38088654 | Mechanisms of RAS/β-catenin interactions |
| Q38071571 | Novel Antineoplastics Targeting Genetic Changes in Colorectal Cancer |
| Q39488912 | Platelet-Derived Growth Factor Regulates Breast Cancer Progression via β-Catenin Expression |
| Q36787608 | Proteoglycans in cancer biology, tumour microenvironment and angiogenesis |
| Q35550094 | Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype |
| Q35200337 | Role of HGF/MET axis in resistance of lung cancer to contemporary management |
| Q27027778 | Signaling cross-talk in the resistance to HER family receptor targeted therapy |
| Q37351482 | The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. |
| Q36515479 | The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies |
| Q33641541 | Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells |
| Q37174369 | Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness |
| Q38160744 | Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells. |
| Q52782089 | WNTing no RASt for hepatocellular carcinoma |
| Q92538604 | Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights |
| Q26746101 | Wnt Signaling in Cancer Stem Cell Biology |
| Q29618024 | Wnt activity defines colon cancer stem cells and is regulated by the microenvironment |
| Q90675233 | Wnt/β-Catenin Signaling and Obesity |
| Q90705173 | Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria |
| Q26825046 | Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis |
| Q84630708 | β-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription |
Search more.